Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atherosclerotic Cardiovascular Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06794684
What this trial is testing

PRogression of Atheroma Evaluated by CT Angiography and IntraCoronary Imaging tEchniques

Who this might be right for
Coronary Arterial Disease (CAD)Coronary Arteriosclerosis
Ruijin Hospital 50,000
Not applicableLooking for participantsNCT07774507
What this trial is testing

Twenty-four Hour Movement Behaviors and Atherosclerotic Risk

Who this might be right for
Cardiovascular Risk AssessmentRheumatoid Arthritis (RA)24-Hour Movement Guidelines
São Paulo State University 150
Testing effectiveness (Phase 2)Study completedNCT05355402
What this trial is testing

Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia

Who this might be right for
HypertriglyceridemiaAtherosclerotic Cardiovascular DiseaseSevere Hypertriglyceridemia
Ionis Pharmaceuticals, Inc. 154
Not applicableUnknownNCT02176941
What this trial is testing

Telomeres and Arterial Aging

Who this might be right for
Atherosclerotic Disease
Central Hospital, Nancy, France 340
Large-scale testing (Phase 3)Study completedNCT02104817
What this trial is testing

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

Who this might be right for
Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
AstraZeneca 13,078
Large-scale testing (Phase 3)Not Yet RecruitingNCT07242599
What this trial is testing

Ongericimab Injection Reducing Recurrence of Ischemic Stroke

Who this might be right for
Ischemic Cerebral Infarction
Beijing Tiantan Hospital 4,810
Testing effectiveness (Phase 2)Study completedNCT04992065
What this trial is testing

A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novo Nordisk A/S 267
Not applicableUnknownNCT06315153
What this trial is testing

Comprehensive Assessment of Atherosclerotic Ischemic Stroke Risk and Development of a Prediction Model

Who this might be right for
Carotid StenosisIschemic Stroke
Xuanwu Hospital, Beijing 500
Not applicableLooking for participantsNCT07594392
What this trial is testing

Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE

Who this might be right for
Atherosclerotic Cardiovascular Disease
St. Jude Children's Research Hospital 650
Testing effectiveness (Phase 2)UnknownNCT01601106
What this trial is testing

Silencing Inflammatory Activity by Injecting Nanocort in Patients at Risk for Atherosclerotic Disease

Who this might be right for
AtherosclerosisInflammation
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 30
Not applicableStudy completedNCT03632785
What this trial is testing

Implications of the Presence of Non-obstructive Atherosclerotic Plaques on Platelet and Vascular Reactivity

Who this might be right for
Discrete Coronary Artery StenosisCoronary Angiography of Multiple DetectorsPlatelet Aggregation, Spontaneous+1 more
University of Sao Paulo 90
Not applicableUnknownNCT00860184
What this trial is testing

SmartRisk Stroke Prediction by MRI of Carotid Disease

Who this might be right for
Atherosclerotic Disease, Carotid
VPDiagnostics 300
Not applicableStudy completedNCT04598685
What this trial is testing

Early Vascular Ageing in the YOUth

Who this might be right for
AtherosclerosisCardiovascular Risk FactorCardiovascular Diseases+11 more
VASCage GmbH 1,517
Not applicableActive Not RecruitingNCT07309705
What this trial is testing

Digital Angiography-Derived Fractional Flow Assessment for Intracranial Stenosis

Who this might be right for
Intracranial Atherosclerosis ICASHemodynamicStroke
Xuanwu Hospital, Beijing 400
Post-approval studies (Phase 4)WithdrawnNCT05515874
What this trial is testing

Predicting Stroke Risk in ICAD With Novel MRI

Who this might be right for
Intracranial Atherosclerosis
Northwestern University
Not applicableLooking for participantsNCT06962488
What this trial is testing

Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure

Who this might be right for
HypertensionAtherosclerotic Cardiovascular Disease
University of Alabama at Birmingham 300
Not applicableStudy completedNCT05619042
What this trial is testing

Detection of Coronary Artery Calcifications by Whole Blood Transcriptome Analyzed by Artificial InTelligence Algorithms

Who this might be right for
AtherosclerosisAtheroscleroses, CoronaryAtherosclerotic Plaque
Santiago Gabriel Miriuka 800
Large-scale testing (Phase 3)Looking for participantsNCT07613294
What this trial is testing

See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

Who this might be right for
AtherosclerosisCardiovascular DiseasesLipoprotein(a)
Eli Lilly and Company 252
Post-approval studies (Phase 4)Study completedNCT05742841
What this trial is testing

EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)

Who this might be right for
Lipid Disorder
Wake Forest University Health Sciences 22
Post-approval studies (Phase 4)Study completedNCT02607748
What this trial is testing

18F-fluoride (18F-NaF) PET for Identifying Coronary Atherosclerotic Plaques

Who this might be right for
Coronary Artery DiseaseAtherosclerotic Plaque
Cedars-Sinai Medical Center 41
Next Page